RMTGRegenerative Medical Technology Group Inc.
Consumer Staples
Net Income (Loss) Attributable to Parent revised down 10.6% for Q2 2025
Net Income (Loss) Attributable to Parent·Q2 2025
Major restatement-$1.4M▼ 10.6%
was-$1.3M
Revised down in a 10-Q.
Verify against SEC filingsShow
As reported-$1.3M
Accepted 2025-08-190001213900-25-078525
Restated-$1.4M
Accepted 2026-08-190001213900-26-091797
NetIncome · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time RMTG — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.